| 摘要: |
| 【目的】克隆山黧豆β-腈基丙氨酸合成酶基因(CASase)DNA全长序列,构建CRISPR/Cas9敲除载体,为筛选“低毒、高硫”山黧豆品系奠定基础。【方法】以萌发4 d山黧豆幼苗根部为材料,提取其基因组DNA,利用PCR克隆CASase基因全长;经序列同源性、内含子、外显子、sgRNA靶位点和脱靶分析后,在CASase cDNA上选取5个sgRNA靶位点进行寡核苷酸链设计和体外活性检测;从5个sgRNA靶位点中取活性较高的4个sgRNA,利用酶切连接法构建基因敲除载体pPLHACas9-sgRNA20r、pPLHACas9-sgRNA68r、pPLHACas9-sgRNA225f和 pPLHACas9-sgRNA256f。【结果】 获得了CASase基因3 143 bp的DNA全长序列,该序列编码β-腈基丙氨酸合成酶;在CASase cDNA中选取5个sgRNA靶位点在体外均能有效剪切靶序列;菌落PCR检测结果显示,4个CRISPR/Cas9基因敲除载体构建成功。【结论】克隆了山黧豆CASase基因DNA全长,成功构建了该基因上4个sgRNA靶位点的CRISPR/Cas9敲除载体。 |
| 关键词: 山黧豆 CASase基因 基因克隆 载体构建 CRISPR/Cas9系统 |
| DOI: |
| 分类号: |
| 基金项目:国家自然科学基金项目(31401910);中国博士后科学基金面上项目(2016M590975);陕西省博士后科研项目(2016BSHEDZZ119);中央高校基本科研业务费资助项目(2014YB040) |
|
| Amplification of CASase gene from Lathyrus sativus and construction of its knock-out vector via CRISPR/Cas9 system |
|
TAO Yingjie,LIU Fengjuan,BI Chunxiao,et al
|
| Abstract: |
| 【Objective】This project cloned full-length DNA sequence of CASase gene from Lathyrus sativus and construct its recombinant knock-out vector via the CRISPR/Cas9 system to provide basis for screening novel lines with low-ODAP and high sulfur-containing amino acids.【Method】The full-length DNA sequence of CASase gene was cloned from radicle DNA of L.sativus via PCR.After alignment,exons and off-target analysis,five target sites on CASase cDNA sequence were selected to design double stranded Oligo DNA and were inserted into pPLatU6-sgRNA,which was then recombined into the expression vector to get pPLHACas9-sgRNA20r,pPLHACas9-sgRNA68r,pPLHACas9-sgRNA225f and pPLHACas9-sgRNA256f.【Result】The full length DNA sequence of CASase gene was obtained with 3 143 bp length and encoded β-cyanoalanine synthase (CASase).All the five selected sgRNA worked with target sequence.Colony PCR and sequencing showed that four knockout vectors were conducted successfully.【Conclusion】The full-length DNA sequence of CASase gene was cloned and four knock-out vectors were conducted successfully via the CRISPR/Cas9 system. |
| Key words: Lathyrus sativus CASase gene gene cloning knock-out vector construction CRISPR/Cas9 system |